Emily M. Fox

2.2k total citations
21 papers, 1.5k citations indexed

About

Emily M. Fox is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Emily M. Fox has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Emily M. Fox's work include Estrogen and related hormone effects (7 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and HER2/EGFR in Cancer Research (4 papers). Emily M. Fox is often cited by papers focused on Estrogen and related hormone effects (7 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and HER2/EGFR in Cancer Research (4 papers). Emily M. Fox collaborates with scholars based in United States, United Kingdom and Switzerland. Emily M. Fox's co-authors include Margaret A. Shupnik, Carlos L. Arteaga, Todd W. Miller, Ana M. González-Angulo, Gordon B. Mills, Yu Shyr, Catherine Higham, Rebecca J. Davis, Josefa Andrade and Carlos Garcı́a-Echeverrı́a and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Emily M. Fox

19 papers receiving 1.5k citations

Peers

Emily M. Fox
Jeffry L. Dean United States
Beryl Hartley‐Asp Sweden
Louis W.C. Chow China
Robert Wieder United States
Carlo Capalbo Italy
Kishore Guda United States
John K. Leighton United States
Rainy Umbas Indonesia
Kiyoshi Okamoto Japan
Christopher Twelves United Kingdom
Jeffry L. Dean United States
Emily M. Fox
Citations per year, relative to Emily M. Fox Emily M. Fox (= 1×) peers Jeffry L. Dean

Countries citing papers authored by Emily M. Fox

Since Specialization
Citations

This map shows the geographic impact of Emily M. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily M. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily M. Fox more than expected).

Fields of papers citing papers by Emily M. Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily M. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily M. Fox. The network helps show where Emily M. Fox may publish in the future.

Co-authorship network of co-authors of Emily M. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Emily M. Fox. A scholar is included among the top collaborators of Emily M. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily M. Fox. Emily M. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Julia G., Jordan T. Jones, Maria Ibarra, et al.. (2024). Influenza knowledge and barriers to vaccination in immunosuppressed patients in the pediatric rheumatology clinic. Pediatric Rheumatology. 22(1). 104–104. 1 indexed citations
2.
Harris, Julia G., Jordan T. Jones, Emily M. Fox, et al.. (2024). Improving Pneumococcal Vaccination Rates in Immunosuppressed Pediatric Patients with Rheumatic Disease. Pediatric Quality and Safety. 9(3). e725–e725.
3.
Fox, Emily M., Mark Bounthavong, Lina Meng, et al.. (2022). Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia. BMC Infectious Diseases. 22(1). 855–855. 4 indexed citations
4.
Ha, David, Sharon Onguti, Amy Chang, et al.. (2022). Sustained Reduction in Urgent Care Antibiotic Prescribing During the Coronavirus Disease 2019 Pandemic: An Academic Medical Center’s Experience. Open Forum Infectious Diseases. 9(2). ofab662–ofab662. 11 indexed citations
5.
6.
Cantrell, Leigh A., A Demi̇rağ, Avinash Kumar Ágarwal, et al.. (2021). Robot‐assisted kidney transplantation is a safe alternative approach for morbidly obese patients with end‐stage renal disease. International Journal of Medical Robotics and Computer Assisted Surgery. 17(5). e2293–e2293. 11 indexed citations
7.
Fox, Emily M., et al.. (2020). Oral retinoid, acitretin, is effective in the management of resistant recurrent vulval verrucous carcinoma: A case report. Journal of obstetrics and gynaecology research. 46(10). 2179–2184. 1 indexed citations
8.
Khozin, Sean, Gideon M. Blumenthal, Lijun Zhang, et al.. (2015). FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer. Clinical Cancer Research. 21(11). 2436–2439. 146 indexed citations
9.
Fox, Emily M., María G. Kuba, Todd W. Miller, Barry R. Davies, & Carlos L. Arteaga. (2013). Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation. Breast Cancer Research. 15(4). R55–R55. 71 indexed citations
10.
Fox, Emily M., et al.. (2013). Common Sense for Caring Organizations: Results from a Study of High-Performing Home Care Agencies and Nursing Homes. 1 indexed citations
11.
Fox, Emily M., Carlos L. Arteaga, & Todd W. Miller. (2012). Abrogating endocrine resistance by targeting ERα and PI3K in breast cancer. SHILAP Revista de lepidopterología. 2. 145–145. 43 indexed citations
12.
Long, Clive G., et al.. (2012). Barriers to treatment: reasons for non‐attendance in women's secure settings. Advances in Dual Diagnosis. 5(4). 154–163. 5 indexed citations
13.
Fox, Emily M., Todd W. Miller, Justin M. Balko, et al.. (2011). A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer. Cancer Research. 71(21). 6773–6784. 131 indexed citations
14.
Miller, Todd W., Justin M. Balko, Emily M. Fox, et al.. (2011). ERα-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer. Cancer Discovery. 1(4). 338–351. 241 indexed citations
15.
Miller, Todd W., Bryan T. Hennessy, Ana M. González-Angulo, et al.. (2010). Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer. Journal of Clinical Investigation. 120(7). 2406–2413. 416 indexed citations
16.
Fox, Emily M., Josefa Andrade, & Margaret A. Shupnik. (2008). Novel actions of estrogen to promote proliferation: Integration of cytoplasmic and nuclear pathways. Steroids. 74(7). 622–627. 128 indexed citations
17.
Fox, Emily M., Rebecca J. Davis, & Margaret A. Shupnik. (2008). ERβ in breast cancer—Onlooker, passive player, or active protector?. Steroids. 73(11). 1039–1051. 128 indexed citations
18.
19.
Boerner, Julie L., Matthew Gibson, Emily M. Fox, et al.. (2005). Estrogen Negatively Regulates Epidermal Growth Factor (EGF)-Mediated Signal Transducer and Activator of Transcription 5 Signaling in Human EGF Family Receptor-Overexpressing Breast Cancer Cells. Molecular Endocrinology. 19(11). 2660–2670. 28 indexed citations
20.
Pickett, Carol L., et al.. (2004). Patterns of Variations in Escherichia coli Strains That Produce Cytolethal Distending Toxin. Infection and Immunity. 72(2). 684–690. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffry L. Dean Breakdown of academic impact, for papers by Beryl Hartley‐Asp Breakdown of academic impact, for papers by Louis W.C. Chow Breakdown of academic impact, for papers by Robert Wieder Breakdown of academic impact, for papers by Carlo Capalbo Breakdown of academic impact, for papers by Kishore Guda Breakdown of academic impact, for papers by John K. Leighton Breakdown of academic impact, for papers by Rainy Umbas Breakdown of academic impact, for papers by Kiyoshi Okamoto Breakdown of academic impact, for papers by Christopher Twelves
Rankless by CCL
2026